The purpose of core A is to provide investigators in the Program Project with access to standardized procedures for the study and quantitative description of processes relevant to thrombus formation under the influence of defined flow forces, in ex vivo models or within the circulatory system of a whole animal. Moreover, the core will help investigators with the isolation and/or culture of relevant vascular cells under static and flow conditions. Project 1 (Ruggeri) will utilize ex vivo perfusion chambers to study the volume of thrombi deposited on selected thrombogenic substrates, including different types of purified collagens and different extracellular matrices (ECMs) under conditions mimicking different hemodynamic environments. Project 1will utilize intravital microscopy techniques to study thrombus formation in different mice with targeted alterations of platelet and matrix proteins. Project 1 will use 40% of core A resources. Project 2 (Ginsberg) will utilize the core service to isolate endothelial cells from mice with targeted mutations of proteins relevant to fibronectin matrix assembly and will study the effect of shear forces on the structure and thrombogenicity of deposited ECM. Project 2 will also study the effects of inhibitors of specific signaling pathways on the alignment of stress fibers in endothelial cells exposed to shear stress, and the possible related changes in matrix thrombogenicity. Project 2 will use 15% of core A resources. Project 3 (Ruf) will study several aspects of tissue factor (TF) functional modulation using endothelial cells and fibroblasts prepared in core A. Specifically, project 3 will examine the mechanisms through which TF becomes associated with ECM, and whether cryptic TF in matrices becomes active through oxidation. Project 3 will use 15% of core A resources. Project 4 (Griffin) will use intravital videomicroscopy to study the antithrombotic properties of wild type and mutant activated protein C. Project 4 will use 30% of core A resources.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL031950-24
Application #
7682278
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
24
Fiscal Year
2008
Total Cost
$312,815
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sinha, Ranjeet K; Wang, Yaoming; Zhao, Zhen et al. (2018) PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. Blood 131:1163-1171
Xu, Xiaohong Ruby; Wang, Yiming; Adili, Reheman et al. (2018) Apolipoprotein A-IV binds ?IIb?3 integrin and inhibits thrombosis. Nat Commun 9:3608
Gupta, Naveen; Liu, Roland; Shin, Stephanie et al. (2018) SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity. J Antimicrob Chemother 73:1586-1594
Gupta, Naveen; Sinha, Ranjeet; Krasnodembskaya, Anna et al. (2018) The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. Stem Cells 36:796-806
Amar, Arun Paul; Sagare, Abhay P; Zhao, Zhen et al. (2018) Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology 134:293-301
Klann, Jane E; Kim, Stephanie H; Remedios, Kelly A et al. (2018) Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance. J Immunol 200:4012-4023
Griffin, John H; Zlokovic, Berislav V; Mosnier, Laurent O (2018) Activated protein C, protease activated receptor 1, and neuroprotection. Blood 132:159-169
Kamikubo, Yuichi; Mendolicchio, G Loredana; Zampolli, Antonella et al. (2017) Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. Blood 130:1661-1670
Rothmeier, Andrea S; Marchese, Patrizia; Langer, Florian et al. (2017) Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking. Arterioscler Thromb Vasc Biol 37:1323-1331
Subramaniam, Saravanan; Jurk, Kerstin; Hobohm, Lukas et al. (2017) Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129:2291-2302

Showing the most recent 10 out of 428 publications